Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1.

Cell | Mar 22, 1996

http://www.ncbi.nlm.nih.gov/pubmed/8601310

The 2.6 Angstrom crystal structure for human cyclin-dependent kinase 2(CDK2) in complex with CksHs1, a human homolog of essential yeast cell cycle-regulatory proteins suc1 and Cks1, reveals that CksHs1 binds via all four beta strands to the kinase C-terminal lobe. This interface is biologically critical, based upon mutational analysis, but far from the CDK2 N-terminal lobe, cyclin, and regulatory phosphorylation sites. CDK2 binds the Cks single domain conformation and interacts with conserved hydrophobic residues plus His-60 and Glu-63 in their closed beta-hinge motif conformation. The beta hinge opening to form the Cks beta-interchanged dimer sterically precludes CDK2 binding, providing a possible mechanism regulating CDK2-Cks interactions. One face of the complex exposes the sequence-conserved phosphate-binding region on Cks and the ATP-binding site on CDK2, suggesting that CKs may target CDK2 to other phosphoproteins during the cell cycle.

Pubmed ID: 8601310 RIS Download

Mesh terms: Base Sequence | CDC2-CDC28 Kinases | Carrier Proteins | Cell Cycle | Cell Cycle Proteins | Conserved Sequence | Crystallography | Cyclin-Dependent Kinase 2 | Cyclin-Dependent Kinases | DNA Mutational Analysis | Humans | Image Processing, Computer-Assisted | Molecular Sequence Data | Protein Binding | Protein Conformation | Protein Kinases | Protein-Serine-Threonine Kinases | Saccharomyces cerevisiae | Sensitivity and Specificity | Sequence Homology, Amino Acid

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.